1. Home
  2. EQH vs KTTA Comparison

EQH vs KTTA Comparison

Compare EQH & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equitable Holdings Inc.

EQH

Equitable Holdings Inc.

HOLD

Current Price

$48.74

Market Cap

13.2B

Sector

Finance

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$1.17

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQH
KTTA
Founded
1859
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
5.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EQH
KTTA
Price
$48.74
$1.17
Analyst Decision
Buy
Strong Buy
Analyst Count
12
1
Target Price
$64.33
$3.00
AVG Volume (30 Days)
2.4M
17.5M
Earning Date
02-04-2026
11-13-2025
Dividend Yield
2.22%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,224,000,000.00
N/A
Revenue This Year
$23.84
N/A
Revenue Next Year
$7.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.38
N/A
52 Week Low
$41.39
$0.28
52 Week High
$56.61
$3.85

Technical Indicators

Market Signals
Indicator
EQH
KTTA
Relative Strength Index (RSI) 60.19 59.44
Support Level $47.40 $1.02
Resistance Level $49.08 $1.21
Average True Range (ATR) 0.92 0.09
MACD 0.21 -0.01
Stochastic Oscillator 86.03 50.22

Price Performance

Historical Comparison
EQH
KTTA

About EQH Equitable Holdings Inc.

Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: